Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-20

Clinical Trial Update: Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis. [Phase 3]

View source ↗

Summary

A pivotal Phase 3 trial of NPNP-001 for knee osteoarthritis is currently enrolling by invitation, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NPNP-001

Snippet

Sponsor: PharmaResearch Co.,Ltd | Conditions: Knee Osteoarthritis | Phase 3 | Status: ENROLLING_BY_INVITATION